Please login to the form below

Not currently logged in
Email:
Password:

pSivida Strengthens board with new non-executive director

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Dr Woodthorpe is CEO of AVCAL (Australian Private Equity and Venture Capital Association) and has an extensive background as a management adviser and director, including working with Australian technology companies seeking venture funding to being a board member of listed companies. She has also consulted with government groups on innovation and commercialisation.

Woodthorpe is also chair of the Antarctic Climate and Ecosystems Cooperative Research Centre, director of Insearch and a council member of the University of Technology Sydney.

pSivida's managing director, Dr Paul Ashton, said: "We are very fortunate to have Katherine join the board. Katherine brings a unique and powerful blend of scientific and business skills that we believe will greatly assist pSivida."

Prior to AVCAL, Woodthorpe worked as a professional non-executive director and management adviser. Her areas of expertise included developing strategies for rapid growth and commercialization of technology products and services.

Stephen Lake, who joined pSivida's board in July 2004 decided to stand down as a director to focus on the launch of a new technology fund in the UK.

6th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics